HK1030373A1 - Oxazolidinone derivatives and pharmaceutical compositions. - Google Patents

Oxazolidinone derivatives and pharmaceutical compositions.

Info

Publication number
HK1030373A1
HK1030373A1 HK01101329A HK01101329A HK1030373A1 HK 1030373 A1 HK1030373 A1 HK 1030373A1 HK 01101329 A HK01101329 A HK 01101329A HK 01101329 A HK01101329 A HK 01101329A HK 1030373 A1 HK1030373 A1 HK 1030373A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
oxazolidinone derivatives
organisms
compound
formula
Prior art date
Application number
HK01101329A
Other languages
English (en)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HK1030373A1 publication Critical patent/HK1030373A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
HK01101329A 1997-11-12 2001-02-23 Oxazolidinone derivatives and pharmaceutical compositions. HK1030373A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK1030373A1 true HK1030373A1 (en) 2001-05-04

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101329A HK1030373A1 (en) 1997-11-12 2001-02-23 Oxazolidinone derivatives and pharmaceutical compositions.

Country Status (22)

Country Link
US (1) US5998406A (xx)
EP (1) EP1030852B1 (xx)
JP (1) JP2001522849A (xx)
KR (1) KR20010031953A (xx)
CN (1) CN1154644C (xx)
AT (1) ATE250054T1 (xx)
AU (1) AU739055B2 (xx)
BR (1) BR9813985A (xx)
CA (1) CA2303959A1 (xx)
DE (1) DE69818294T2 (xx)
DK (1) DK1030852T3 (xx)
ES (1) ES2207010T3 (xx)
HK (1) HK1030373A1 (xx)
HU (1) HUP0100470A3 (xx)
IL (1) IL136062A (xx)
NO (1) NO317291B1 (xx)
NZ (1) NZ504503A (xx)
PT (1) PT1030852E (xx)
RU (1) RU2215740C2 (xx)
SK (1) SK284577B6 (xx)
TR (1) TR200001330T2 (xx)
WO (1) WO1999024428A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002517498A (ja) 1998-06-05 2002-06-18 アストラゼネカ アクチボラグ 化学化合物
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
WO2004014897A1 (en) * 2002-08-12 2004-02-19 Pharmacia & Upjohn Company Llc N-aryl-2-oxazolidinones and their derivatives
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
CA2536480A1 (en) * 2003-08-25 2005-03-03 Warner-Lambert Company Llc Novel antimicrobial aryloxazolidinone compounds
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
JP2008521792A (ja) * 2004-11-29 2008-06-26 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌薬としてのジアゼピンオキサゾリジノン
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
ATE449773T1 (de) 2005-06-29 2009-12-15 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
BRPI0616801B8 (pt) 2005-10-04 2021-05-25 Bayer Healthcare Ag "forma polimórfica de 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofenocarboxamida, seus processos de preparação e seus usos, medicamento, e processo para prevenção de coagulação de sangue in vitro
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
EP2208729A4 (en) 2007-10-02 2011-04-27 Res Found Itsuu Lab OXAZOLIDINONE DERIVATIVE WITH 7-CHAIN HETEROCYCLE
JP2014500247A (ja) 2010-11-03 2014-01-09 ウォックハート リミテッド リン酸モノ−（１−｛４−［（ｓ）―５−（アセチルアミノメチル）−２−オキソ−オキサゾリジン−３−イル］−２，６−ジフルオロフェニル｝−４−メトキシメチルピペリジン−４−イル）エステルの調製方法
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
EP0316594B1 (en) * 1987-10-21 1993-09-29 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
AU617871B2 (en) * 1988-09-15 1991-12-05 Pharmacia & Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2- ones
KR100257418B1 (ko) * 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 치환된 아릴-및 헤테로아릴-페닐옥사졸리디논
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
ATE182142T1 (de) * 1993-11-22 1999-07-15 Upjohn Co Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
HUP0100470A2 (hu) 2002-05-29
IL136062A (en) 2004-02-08
SK6182000A3 (en) 2000-12-11
NO20002434L (no) 2000-05-11
TR200001330T2 (tr) 2000-11-21
SK284577B6 (sk) 2005-07-01
JP2001522849A (ja) 2001-11-20
DE69818294T2 (de) 2004-07-08
IL136062A0 (en) 2001-05-20
RU2215740C2 (ru) 2003-11-10
CA2303959A1 (en) 1999-05-20
EP1030852A1 (en) 2000-08-30
US5998406A (en) 1999-12-07
WO1999024428A1 (en) 1999-05-20
NO20002434D0 (no) 2000-05-11
ES2207010T3 (es) 2004-05-16
CN1271358A (zh) 2000-10-25
KR20010031953A (ko) 2001-04-16
HUP0100470A3 (en) 2002-08-28
PT1030852E (pt) 2004-02-27
AU1277899A (en) 1999-05-31
AU739055B2 (en) 2001-10-04
DK1030852T3 (da) 2003-12-22
NZ504503A (en) 2002-10-25
DE69818294D1 (de) 2003-10-23
EP1030852B1 (en) 2003-09-17
CN1154644C (zh) 2004-06-23
ATE250054T1 (de) 2003-10-15
BR9813985A (pt) 2000-09-26
NO317291B1 (no) 2004-10-04

Similar Documents

Publication Publication Date Title
IL136062A0 (en) Oxazolidinone derivatives and pharmaceutical compositions
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
BG103947A (en) Derivatives of 9-oxymerythromycin
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
WO2001003685A3 (en) Novel prodrugs for antimicrobial amidines
DE69631609D1 (en) Tricyclische erythromycinderivate
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
NZ308518A (en) Antibacterial cephalosporins
GR3036873T3 (en) Dialkyltiacumicin compounds
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
SI0808326T1 (en) Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
SI0801655T1 (en) Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
CA2380455A1 (en) 9a-azalides with antibacterial activity
AU5390900A (en) Potassium channel blocking agents
MY122570A (en) Benzamide derivatives and drugs containing the same
MXPA03010607A (es) Compuesto de carbapenem.
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
WO2000011965A3 (en) Ingestible compositions comprising antibacterial agents
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
DE69840610D1 (de) Antimikrobielle Verbindungen

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081030